858 related articles for article (PubMed ID: 30127785)
1. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
2. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
3. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M
Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220
[TBL] [Abstract][Full Text] [Related]
4. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
5. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.
Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW
Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T-cell epitope prediction using antigen processing constraints.
Mettu RR; Charles T; Landry SJ
J Immunol Methods; 2016 May; 432():72-81. PubMed ID: 26891811
[TBL] [Abstract][Full Text] [Related]
7. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.
Reche PA; Glutting JP; Zhang H; Reinherz EL
Immunogenetics; 2004 Sep; 56(6):405-19. PubMed ID: 15349703
[TBL] [Abstract][Full Text] [Related]
8. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
[TBL] [Abstract][Full Text] [Related]
9. Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes.
Fisch A; Reynisson B; Benedictus L; Nicastri A; Vasoya D; Morrison I; Buus S; Ferreira BR; Kinney Ferreira de Miranda Santos I; Ternette N; Connelley T; Nielsen M
J Immunol; 2021 May; 206(10):2489-2497. PubMed ID: 33789985
[TBL] [Abstract][Full Text] [Related]
10. Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.
Hoze E; Tsaban L; Maman Y; Louzoun Y
J Immunol Methods; 2013 May; 391(1-2):163-73. PubMed ID: 23481624
[TBL] [Abstract][Full Text] [Related]
11. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
[TBL] [Abstract][Full Text] [Related]
12. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.
Wendorff M; Garcia Alvarez HM; Østerbye T; ElAbd H; Rosati E; Degenhardt F; Buus S; Franke A; Nielsen M
Front Immunol; 2020; 11():1705. PubMed ID: 32903714
[TBL] [Abstract][Full Text] [Related]
13. Footprints of antigen processing boost MHC class II natural ligand predictions.
Barra C; Alvarez B; Paul S; Sette A; Peters B; Andreatta M; Buus S; Nielsen M
Genome Med; 2018 Nov; 10(1):84. PubMed ID: 30446001
[TBL] [Abstract][Full Text] [Related]
14. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
15. Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system.
Paul S; Croft NP; Purcell AW; Tscharke DC; Sette A; Nielsen M; Peters B
PLoS Comput Biol; 2020 May; 16(5):e1007757. PubMed ID: 32453790
[TBL] [Abstract][Full Text] [Related]
16. Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.
Racle J; Guillaume P; Schmidt J; Michaux J; Larabi A; Lau K; Perez MAS; Croce G; Genolet R; Coukos G; Zoete V; Pojer F; Bassani-Sternberg M; Harari A; Gfeller D
Immunity; 2023 Jun; 56(6):1359-1375.e13. PubMed ID: 37023751
[TBL] [Abstract][Full Text] [Related]
17. Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions.
Paul S; Grifoni A; Peters B; Sette A
Front Immunol; 2019; 10():3151. PubMed ID: 32117208
[TBL] [Abstract][Full Text] [Related]
18. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
[TBL] [Abstract][Full Text] [Related]
19. Binding motifs predict major histocompatibility complex class II-restricted epitopes in the Sendai virus M protein.
Cole GA; Tao T; Hogg TL; Ryan KW; Woodland DL
J Virol; 1995 Dec; 69(12):8057-60. PubMed ID: 7494321
[TBL] [Abstract][Full Text] [Related]
20. Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction.
Rappazzo CG; Huisman BD; Birnbaum ME
Nat Commun; 2020 Sep; 11(1):4414. PubMed ID: 32887877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]